Proposed Data Collection Submitted for Public Comment and Recommendations, 62867-62869 [2018-26351]
Download as PDF
<![CDATA[
62867
Federal Register / Vol. 83, No. 234 / Thursday, December 6, 2018 / Notices
system to monitor and guide
participating state health departments.
Since implementation in 2010, AIRS
and the technical assistance provided by
CDC staff have provided states with
uniform data reporting methods and
linkages to other states’ asthma program
information and resources. Thus, AIRS
has saved state resources and staff time
when asthma programs embark on
asthma activities similar to those done
elsewhere.
In the past three years, AIRS data
were used to:
• Serve as a resource to NCEH when
addressing congressional, departmental
and institutional inquiries.
• Help the branch align its current
interventions with CDC goals and
allowed the monitoring of progress
toward these goals.
• Allow the NACP and the state
asthma programs to make more
informed decisions about activities to
achieve objectives.
• Facilitate communication about
interventions across states, and enable
inquiries regarding interventions by
populations with a disproportionate
burden, age groups, geographic areas
and other variables of interest.
• Provide feedback to the grantees
about their performance relative to
others through the distribution of two
written reports and several
presentations (webinar and in-person)
summarizing the results.
• Customize and provide technical
assistance and support materials to
address implementation challenges.
There will be no cost to respondents
other than their time to complete the
three AIRS spreadsheets annually. The
estimated annualized burden hours are
89.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State Asthma Program Awardees ....
AIRS Performance Measures Reporting Spreadsheets.
AIRS Emergency Department Visits
Reporting Form.
AIRS Hospital Discharge Reporting
Forms.
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–26352 Filed 12–4–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–19DO; Docket No. CDC–2018–
0108]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
SUMMARY:
khammond on DSK30JT082PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
20:35 Dec 04, 2018
Jkt 247001
150/60
63
25
1
30/60
13
25
1
30/60
13
........................
........................
........................
89
You may submit comments,
identified by Docket No. CDC–2018–
0108 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Acting Lead,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Fmt 4703
Total burden
(in hours)
1
ADDRESSES:
Frm 00035
Average
burden per
response
(in hours)
25
proposed information collection project
titled National Surveillance of
Community Water Systems and
Corresponding Populations with the
Recommended Fluoridation Level. This
surveillance collects the fluoridation
status of the nation’s approximately
52,000 community water systems (CWS)
which serve the 50 states and the
District of Columbia. It also collects
fluoride level testing data for those CWS
which adjust naturally occurring
fluoride levels. The data are analyzed
and published to inform the public and
to support state and local governments’
efforts to monitor community water
fluoridation levels relative to the US
Public Health Service recommended
level to prevent tooth decay.
DATES: CDC must receive written
comments on or before February 4,
2019.
PO 00000
Number of
responses per
respondent
Sfmt 4703
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\06DEN1.SGM
06DEN1
62868
Federal Register / Vol. 83, No. 234 / Thursday, December 6, 2018 / Notices
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Surveillance of Community
Water Systems and Corresponding
Populations with the Recommended
Fluoridation Level—Existing Collection
in use without an OMB Control
Number—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Dental caries is one of the most
common chronic diseases throughout
the lifespan in the United States, and
disproportionately affects populations
with low socioeconomic status, and
racial and ethnic minority populations.
Dental caries can lead to infection and
diminished quality of life, and cause
substantial societal cost due to absence
from school and work, as well as
expensive treatments.
Naturally occurring fluoride is found
in all surface and ground water sources,
but typically is lower than the
recommended concentration needed to
prevent dental caries (tooth decay).
Community water fluoridation is the
process of adjusting the fluoride
concentration of a community water
system (CWS) to the level beneficial for
prevention of dental caries as
recommended by the US Public Health
Service (PHS). CDC monitors CWS
fluoride levels relative to the PHS
recommended level under the Public
Health Service Act. In 2000, CDC
launched a Web-based data management
tool—Water Fluoridation Reporting
Systems (WFRS) in collaboration with
the Association of State and Territorial
Dental Directors. States may report their
information to CDC using WFRS or via
email.
Respondents to the information
collection are state fluoridation
managers or other state government
officials designated by the state dental
director or drinking water administrator.
State participation in the data collection
is voluntary. Respondents are asked to
update fluoridation status of, and
counties and populations served by,
each CWS in their state annually. All 50
states respond to this portion of the
collection. Washington DC is not
included in the data collection because
water is supplied by a CWS from
Virginia and therefore Virginia will
collect data. Historically collected
natural fluoride concentrations are
available in WFRS for all CWS; once
collected, they rarely change over time.
Respondents also are asked to enter the
high, low, and average fluoride testing
level data annually for each month for
their fluoride-adjusted CWS. Currently,
two-thirds of the states respond to this
portion of the collection.
CDC analyzes and publishes results
through interactive, public-facing web
pages: (1) Biennial surveillance reports
documenting the percentage of the
population with fluoridated water at
national, state, and local levels; and (2)
My Water’s Fluoride, which publishes
the fluoridation status of individual
CWS and some fluoride level data for
states which choose to display it. CDC
uses the information collection to (1)
provide national fluoridation
surveillance reports; (2) assist states
manage their fluoride level data and
monitor and improve quality of
community water fluoridation
programs; (3) measure national
performance toward the fluoridation
Healthy People objective; (4) evaluate
outcomes of CDC’s cooperative
agreements with states; (5) facilitate
creation of state-specific reports for
states’ programmatic and policy use.
The information collection is also used
to inform health care providers to
determine targeted delivery of
preventive care, for example,
determining use of fluoride
supplements for children living in
fluoride-deficient areas.
CDC’s collection of CWS data is not
duplicative of any other federal
collection, including the US
Environmental Protection Agency’s
(EPA) Safe Drinking Water Information
System (SDWIS), as SDWIS receives
state reports of CWS fluoride levels that
exceed 4 mg/L but not those near the
beneficial level of 0.7 mg/L
recommended for dental caries
prevention by the PHS. Thus, CDC’s
system is required to assess the degree
to which the nation is reaching this
PHS-recommended level.
The total estimated annualized
burden hours are 2,824, including (1)
1,900 hours for the validation or update
of CWS fluoridation status and
population served from 50 respondents,
with estimated average burden hours of
38 per respondent; and (2) 924 hours for
the annual entry of fluoride testing level
data for fluoride-adjusted CWS
conducted by 33 respondents with an
estimated average burden of 28 hours
per respondent. WFRS will be hosted
and maintaineded by CDC. There are no
maintenance costs to respondents, and
there are no costs to respondents other
than their time.
khammond on DSK30JT082PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
State Official ......................................
State Official ......................................
Fluoridation status and population ...
Fluoride testing data ........................
50
33
1
1
38
28
1,900
924
Total ...........................................
...........................................................
........................
........................
........................
2,824
VerDate Sep<11>2014
20:35 Dec 04, 2018
Jkt 247001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\06DEN1.SGM
06DEN1
Federal Register / Vol. 83, No. 234 / Thursday, December 6, 2018 / Notices
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2018–26351 Filed 12–4–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Notice of Hearing: Reconsideration of
Disapproval Washington Medicaid
State Plan Amendment (SPA) 17–0002
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of hearing:
reconsideration of disapproval.
AGENCY:
This notice announces an
administrative hearing to be held on
January 15, 2019, at the Department of
Health and Human Services, Centers for
Medicare & Medicaid Services, Division
of Medicaid and Children’s Health,
Seattle Regional Office, 701 Fifth
Avenue, Suite 1600, Seattle, WA 98104
to reconsider CMS’ decision to
disapprove Washington’s Medicaid SPA
17–0002.
DATES: Requests to participate in the
hearing as a party must be received by
the presiding officer by December 20,
2018.
FOR FURTHER INFORMATION CONTACT:
Benjamin R. Cohen, Presiding Officer,
CMS, 2520 Lord Baltimore Drive, Suite
L, Baltimore, Maryland 21244,
Telephone: (410) 786–3169.
SUPPLEMENTARY INFORMATION: This
notice announces an administrative
hearing to reconsider CMS’ decision to
disapprove Washington’s Medicaid state
plan amendment (SPA) 17–0002, which
was submitted to the Centers for
Medicare & Medicaid Services (CMS) on
June 26, 2017 and disapproved on
September 10, 2018. This SPA requested
CMS approval to: Bring Washington into
compliance with the pharmacy
reimbursement requirements in the
Covered Outpatient Drugs final rule
with comment period (CMS–2345–FC)
(Final Rule). Specifically, SPA 17–0002
proposed to revise the current pharmacy
reimbursement methodology from
reimbursing for ingredient costs based
on Estimated Acquisition Cost (EAC),
plus a tiered dispensing fee (Highvolume pharmacies $4.24/Rx, Midvolume pharmacies $4.56/Rx, Lowvolume pharmacies $5.25/Rx, and Unit
Does System $5.25/Rx), to reimbursing
for ingredient cost based on Actual
khammond on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:35 Dec 04, 2018
Jkt 247001
Acquisition Cost (AAC), using the
National Average Drug Acquisition Cost
(NADAC) without a change in the new
requirements for a professional
dispensing fee. In addition, SPA 17–
0002 included proposed changes to
reimbursement for 340B drugs,
physician-administered drugs, clotting
factor, federal supply schedule, and
drugs purchased at nominal price.
The issues to be considered at the
hearing are whether Washington SPA
17–0002 is inconsistent with the
requirements of:
• Section 1902(a)(30)(A) of the Social
Security Act (the Act) which requires, in
part, that states have a state plan that
provides such methods and procedures
to assure that payment rates are
consistent with efficiency, economy,
and quality of care and are sufficient to
enlist enough providers so that care and
services are available under the plan at
least to the extent that such care and
services are available to the general
population in the geographic area.
• Federal regulations at 42 CFR
447.502, 447.512 and 447.518 which
provide that payments for drugs are to
be based on the ingredient cost of the
drug based on AAC and a Professional
Dispensing Fee (PDF).
Section 1116 of the Act and federal
regulations at 42 CFR part 430 establish
Department procedures that provide an
administrative hearing for
reconsideration of a disapproval of a
state plan or plan amendment. CMS is
required to publish in the Federal
Register a copy of the notice to a state
Medicaid agency that informs the
agency of the time and place of the
hearing, and the issues to be considered.
If we subsequently notify the state
Medicaid agency of additional issues
that will be considered at the hearing,
we will also publish that notice in the
Federal Register.
Any individual or group that wants to
participate in the hearing as a party
must petition the presiding officer
within 15 days after publication of this
notice, in accordance with the
requirements contained at 42 CFR
430.76(b)(2). Any interested person or
organization that wants to participate as
amicus curiae must petition the
presiding officer before the hearing
begins in accordance with the
requirements contained at 42 CFR
430.76(c). If the hearing is later
rescheduled, the presiding officer will
notify all participants.
The notice to Washington announcing
an administrative hearing to reconsider
the disapproval of its SPA reads as
follows:
Ms. MaryAnne Lindeblad
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
62869
Director
State of Washington, Health Care
Authority
626 8th Avenue PO Box 45502
Olympia, WA 98504–5050
Dear Ms. Lindeblad:
I am responding to your November 5,
2018 request for reconsideration of the
decision to disapprove Washington’s
State Plan amendment (SPA) 17–0002.
Washington SPA 17–0002 was
submitted to the Centers for Medicare &
Medicaid Services (CMS) on June 26,
2017, and disapproved on September
10, 2018. I am scheduling a hearing on
your request for reconsideration to be
held on January 15, 2019, at the
Department of Health and Human
Services, Centers for Medicare &
Medicaid Services, Division of Medicaid
and Children’s Health, Seattle Regional
Office, 701 Fifth Avenue, Suite 1600,
Seattle, WA 98104.
I am designating Mr. Benjamin R.
Cohen as the presiding officer. If these
arrangements present any problems,
please contact Mr. Cohen at (410) 786–
3169. In order to facilitate any
communication that may be necessary
between the parties prior to the hearing,
please notify the presiding officer to
indicate acceptability of the hearing
date that has been scheduled and
provide names of the individuals who
will represent the State at the hearing.
If the hearing date is not acceptable, Mr.
Cohen can set another date mutually
agreeable to the parties. The hearing
will be governed by the procedures
prescribed by federal regulations at 42
CFR part 430.
This SPA requested CMS approval to
bring Washington into compliance with
the pharmacy reimbursement
requirements in the Covered Outpatient
Drugs final rule with comment period
(CMS–2345–FC) (Final Rule).
Specifically, SPA 17–0002 proposed to
revise the current pharmacy
reimbursement methodology from
reimbursing for ingredient costs based
on Estimated Acquisition Cost (EAC),
plus a tiered dispensing fee (Highvolume pharmacies $4.24/Rx, Midvolume pharmacies $4.56/Rx, Lowvolume pharmacies $5.25/Rx, and Unit
Does System $5.25/Rx), to reimbursing
for ingredient cost based on Actual
Acquisition Cost (AAC), using the
National Average Drug Acquisition Cost
(NADAC) without a change in the new
requirements for a professional
dispensing fee. In addition, SPA 17–
0002 included proposed changes to
reimbursement for 340B drugs,
physician-administered drugs, clotting
factor, federal supply schedule, and
drugs purchased at nominal price.
E:\FR\FM\06DEN1.SGM
06DEN1
]]>Agencies
[Federal Register Volume 83, Number 234 (Thursday, December 6, 2018)]
[Notices]
[Pages 62867-62869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26351]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-19DO; Docket No. CDC-2018-0108]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled National Surveillance of
Community Water Systems and Corresponding Populations with the
Recommended Fluoridation Level. This surveillance collects the
fluoridation status of the nation's approximately 52,000 community
water systems (CWS) which serve the 50 states and the District of
Columbia. It also collects fluoride level testing data for those CWS
which adjust naturally occurring fluoride levels. The data are analyzed
and published to inform the public and to support state and local
governments' efforts to monitor community water fluoridation levels
relative to the US Public Health Service recommended level to prevent
tooth decay.
DATES: CDC must receive written comments on or before February 4, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0108 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Acting Lead, Information
Collection Review Office, Centers for Disease Control and Prevention,
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are
[[Page 62868]]
publishing this notice of a proposed data collection as described
below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
National Surveillance of Community Water Systems and Corresponding
Populations with the Recommended Fluoridation Level--Existing
Collection in use without an OMB Control Number--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Dental caries is one of the most common chronic diseases throughout
the lifespan in the United States, and disproportionately affects
populations with low socioeconomic status, and racial and ethnic
minority populations. Dental caries can lead to infection and
diminished quality of life, and cause substantial societal cost due to
absence from school and work, as well as expensive treatments.
Naturally occurring fluoride is found in all surface and ground
water sources, but typically is lower than the recommended
concentration needed to prevent dental caries (tooth decay). Community
water fluoridation is the process of adjusting the fluoride
concentration of a community water system (CWS) to the level beneficial
for prevention of dental caries as recommended by the US Public Health
Service (PHS). CDC monitors CWS fluoride levels relative to the PHS
recommended level under the Public Health Service Act. In 2000, CDC
launched a Web-based data management tool--Water Fluoridation Reporting
Systems (WFRS) in collaboration with the Association of State and
Territorial Dental Directors. States may report their information to
CDC using WFRS or via email.
Respondents to the information collection are state fluoridation
managers or other state government officials designated by the state
dental director or drinking water administrator. State participation in
the data collection is voluntary. Respondents are asked to update
fluoridation status of, and counties and populations served by, each
CWS in their state annually. All 50 states respond to this portion of
the collection. Washington DC is not included in the data collection
because water is supplied by a CWS from Virginia and therefore Virginia
will collect data. Historically collected natural fluoride
concentrations are available in WFRS for all CWS; once collected, they
rarely change over time. Respondents also are asked to enter the high,
low, and average fluoride testing level data annually for each month
for their fluoride-adjusted CWS. Currently, two-thirds of the states
respond to this portion of the collection.
CDC analyzes and publishes results through interactive, public-
facing web pages: (1) Biennial surveillance reports documenting the
percentage of the population with fluoridated water at national, state,
and local levels; and (2) My Water's Fluoride, which publishes the
fluoridation status of individual CWS and some fluoride level data for
states which choose to display it. CDC uses the information collection
to (1) provide national fluoridation surveillance reports; (2) assist
states manage their fluoride level data and monitor and improve quality
of community water fluoridation programs; (3) measure national
performance toward the fluoridation Healthy People objective; (4)
evaluate outcomes of CDC's cooperative agreements with states; (5)
facilitate creation of state-specific reports for states' programmatic
and policy use. The information collection is also used to inform
health care providers to determine targeted delivery of preventive
care, for example, determining use of fluoride supplements for children
living in fluoride-deficient areas.
CDC's collection of CWS data is not duplicative of any other
federal collection, including the US Environmental Protection Agency's
(EPA) Safe Drinking Water Information System (SDWIS), as SDWIS receives
state reports of CWS fluoride levels that exceed 4 mg/L but not those
near the beneficial level of 0.7 mg/L recommended for dental caries
prevention by the PHS. Thus, CDC's system is required to assess the
degree to which the nation is reaching this PHS-recommended level.
The total estimated annualized burden hours are 2,824, including
(1) 1,900 hours for the validation or update of CWS fluoridation status
and population served from 50 respondents, with estimated average
burden hours of 38 per respondent; and (2) 924 hours for the annual
entry of fluoride testing level data for fluoride-adjusted CWS
conducted by 33 respondents with an estimated average burden of 28
hours per respondent. WFRS will be hosted and maintaineded by CDC.
There are no maintenance costs to respondents, and there are no costs
to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
State Official................ Fluoridation 50 1 38 1,900
status and
population.
State Official................ Fluoride testing 33 1 28 924
data.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,824
----------------------------------------------------------------------------------------------------------------
[[Page 62869]]
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2018-26351 Filed 12-4-18; 8:45 am]
BILLING CODE 4163-18-P
